Neelam Bhardwaj

Chimeric Antigen Receptor (CAR) therapy for multiple myeloma

T. Luetkens, D. Atanackovic, S. Radhakrishnan, 2016, British journal of haematology.

Chimeric Antigen Receptor (CAR) T Cells Specific for CD229: A Potentially Curative Approach for Multiple Myeloma

T. Luetkens, D. Atanackovic, D. Sborov, 2017 .

CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma

J. Panse, T. Luetkens, N. Kröger, 2015, Human vaccines & immunotherapeutics.

Novel anti-myeloma immunotherapies targeting the SLAM family of receptors

T. Luetkens, D. Atanackovic, S. Radhakrishnan, 2017, Oncoimmunology.

Elotuzumab as a novel anti-myeloma immunotherapy

T. Luetkens, D. Atanackovic, S. Radhakrishnan, 2017, Human vaccines & immunotherapeutics.